Company: ACHV
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059297
Chunk: 37

Company: ACHIEVE LIFE SCIENCES, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 37
---
       — |
| All non-employee directors, as a group (6 persons)                    |     |                       | 189,000 |
| All employees who are not executive officers or directors, as a group |     |                       |       — |

(1) All equity awards expected to be granted in fiscal year 2025 under the Plan are option grants. Vote Required and Board of Directors Recommendation The affirmative vote of a majority of the shares of common stock properly cast at the Annual Meeting is required to approve this proposal.

| THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS THAT STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE AMENDMENT TO OUR 2023 NON-EMPLOYEE DIRECTOR EQUITY INCENTIVE PLAN. |

28

EXEC UTIVE OFFICERS The following table provides information regarding our current executive officers as of April 15, 2025.

| Name               |     | Age |     | Position With the Company           |
| Cindy Jacobs       |     |  68 |     | President and Chief Medical Officer |
| Thomas B. King(1)  |     |  70 |     | Interim Executive Chairman          |
| Mark Oki           |     |  56 |     | Chief Financial Officer             |
| Richard Stewart(2) |     |  66 |     | Chief Executive Officer             |
| Jaime Xinos        |     |  48 |     | Chief Commercial Officer            |

(1) Mr. King became Interim Executive Chairman in August 2024 and will assume the position of independent Chairman of the Board effective upon the Annual Meeting. (2) Mr. Stewart was appointed to his position on August 21, 2024 following the resignation of Mr. Bencich. He previously held the position of Executive Chairman with the Company. Following is the biography of Cindy Jacobs, Mark Oki and Jaime Xinos. The biographies of Mr. Stewart, and Mr. King are located above under the heading “Board of Directors—General.” Cindy Jacobs , Ph.D., M.D., has served as our President since September 2020 and our Chief Medical Officer since August 2017, and a member of the Board of Directors since March 2021. Previously, Dr. Jacobs served as Executive Vice President and Chief Medical Officer of OncoGenex Pharmaceuticals, Inc. from September 2005 to August 2017. Dr. Jacobs is also the founder of Eagles Ridge Executive Consulting LLC., an executive